Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients

NCT02039518 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: gemcitabine
OTHER: observation group

Sponsor

Fudan University